Ignite Creation Date:
2024-05-06 @ 12:50 AM
Last Modification Date:
2024-10-26 @ 10:55 AM
Study NCT ID:
NCT01661283
Status:
COMPLETED
Last Update Posted:
2019-03-06
First Post:
2012-08-07
Brief Title:
SARC016 Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
Sponsor:
Sarcoma Alliance for Research through Collaboration
Organization:
Sarcoma Alliance for Research through Collaboration
Organization Data
Organization:
Sarcoma Alliance for Research through Collaboration
Class:
OTHER
Study ID:
SARC016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sarcoma Alliance for Research through Collaboration
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| United States Department of Defense | FED |
| Novartis Pharmaceuticals | INDUSTRY |
| Genentech Inc | INDUSTRY |